Missouri 2026 Regular Session

Missouri House Bill HB1826

Introduced
1/7/26  
Refer
1/15/26  
Report Pass
2/5/26  
Refer
2/19/26  
Report Pass
2/26/26  
Engrossed
3/16/26  
Engrossed
3/19/26  
Refer
3/31/26  

Caption

Modifies provisions relating to epinephrine delivery systems

Impact

The legislation is expected to have a significant impact on state laws concerning health and safety regulations. If enacted, HB 1826 would likely lead to enhanced training requirements for individuals and entities involved in the handling of epinephrine delivery systems, such as schools and first responders. The bill's supporters argue that with clearer guidelines, there will be fewer obstacles to accessing these vital medications in emergencies, ultimately fostering a safer environment for individuals who may suffer from anaphylactic reactions.

Summary

House Bill 1826 aims to modify the provisions relating to epinephrine delivery systems, which are crucial for individuals experiencing severe allergic reactions. The bill seeks to establish clearer regulations surrounding the transportation and use of these delivery systems, making them more accessible in emergency situations. By creating a standardized approach, the bill's proponents hope to improve response rates and manage allergic emergencies more effectively, potentially saving lives in critical scenarios where timely medication administration is essential.

Sentiment

The sentiment surrounding HB 1826 appears to be generally positive, particularly among healthcare professionals and advocacy groups focused on allergy awareness and emergency response. Supporters highlight the importance of making epinephrine more readily available and ensuring that those who might need it have access without undue restrictions. However, there may also be concerns from some quarters about the feasibility of implementing training and compliance measures, which could be seen as a burden on schools and local organizations.

Contention

Notable points of contention surrounding the bill may arise from the implementation of the training protocols and the responsibilities placed on schools and emergency services. Critics might argue that the training mandates could impose additional costs and logistical challenges, potentially deterring some entities from fully complying with the new regulations. The balancing act between improving emergency response and ensuring that those responsible for administering medication do not face undue hardship will be a key focus in any discussions about the practical implications of HB 1826.

Companion Bills

No companion bills found.

Previously Filed As

MO HB553

Modifies provisions relating to epinephrine products

MO SB94

Modifies provisions relating to health care

MO SB7

Modifies provisions relating to health care

MO SB548

Modifies provisions relating to health care

MO HB165

Modifies provisions relating to epinephrine products

MO SB317

Modifies provisions relating to health care

MO SB783

Requires child care facilities to adopt allergy policies

MO SB61

Modifies provisions relating to professional licensing

MO HB1195

Modifies provisions relating to access to medical products

MO SB369

Modifies certain provisions relating to solar energy systems

Similar Bills

No similar bills found.